XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows (Unauidted) - USD ($)
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash Flows from Operating Activities:    
Net loss from continuing operation $ (3,550,669) $ (2,641,658)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 10,043 13,895
Stock compensation expense 62,250 148,100
Non cash investment income from Shuya (57,980)
Loss on deconsolidation of Shuya 145,677
Gain on debt settlement (130,430)
Amortization of debt discount 133,053 918,640
Change in derivative liability (326,539)
Changes in assets and liabilities:    
(Increase) decrease in right of use asset 37,591 128,748
(Decrease) increase in lease liability (35,289) (142,711)
(Increase) decrease in accounts receivable (9,228) (538,040)
(Increase) decrease in accounts receivable - related party (548,108)
(Increase) decrease in prepayments 491,500 (1,245,320)
(Increase) decrease in equity method investment
(Increase) decrease in other assets 111,952 695,777
(Increase) decrease in inventory (231,760) (49,214)
(Increase) decrease in tax receivable (43,639)
(Decrease) increase in accounts payable 540,614 (404,734)
Other (Decrease) increase in accrued expenses 145,116 (230,545)
Other (Decrease) increase in accrued interest 133,756 104,694
Other (Decrease) increase in other payables - related party (705,560)
Other (Decrease) increase in customer deposits (123,489) 647,633
Net cash used in continuing operations (2,788,608) (3,757,264)
Net cash used in discontinued operations   (84,968)
Net Cash Used In Operating Activities (2,788,608) (3,842,232)
Cash Flows from Investing Activities    
Loan receivable 83,340
Purchase of intangible assets (90)
Net cash provided by/(used in) continuing operations 83,340 (90)
Net cash provided by discontinued operations   14,201
Net Cash Provided by Investing Activities 83,340 14,111
Cash Flows from Financing Activities    
Proceeds from notes payable and lines of credit 1,425,520 1,310,538
Payments on notes payables and lines of credit (644,257) (1,463,049)
Proceeds from warrants exercised 693,603
Loan receivable (104,227) (14,220)
Stock issued for cash 1,983,000 3,145,244
Net cash provided by continuing operations 2,660,036 3,672,116
Net cash provided by discontinued operations   234,382
Net Cash Provided By Financing Activities 2,660,036 3,906,498
Foreign currency translation (245) 36,165
Net Increase (Decrease) in Cash and Cash Equivalents (45,477) 114,542
Cash and Cash Equivalents at Beginning of Period 89,625 149,272
Cash and Cash Equivalents at End of Period 44,149 263,814
Supplemental Cash flow Information:    
Interest Paid 99,214 263,053
Taxes Paid
Supplemental non-cash disclosure    
Shares issued for preferred conversions 2,115
Dividend accrued 108,842
Discounts on new notes 239,800
Universal convertible note principal and accrued interest conversion 666,250
Warrants issued in conjunction for convertible notes payable 609,617
Shares issued for warrants 261,639
Shares issued for debt conversion conversions